Long COVID science, research and policy DOI Creative Commons
Ziyad Al‐Aly, Hannah Davis, Lisa McCorkell

et al.

Nature Medicine, Journal Year: 2024, Volume and Issue: 30(8), P. 2148 - 2164

Published: Aug. 1, 2024

Long COVID represents the constellation of post-acute and long-term health effects caused by SARS-CoV-2 infection; it is a complex, multisystem disorder that can affect nearly every organ system be severely disabling. The cumulative global incidence long around 400 million individuals, which estimated to have an annual economic impact approximately $1 trillion-equivalent about 1% economy. Several mechanistic pathways are implicated in COVID, including viral persistence, immune dysregulation, mitochondrial dysfunction, complement endothelial inflammation microbiome dysbiosis. devastating impacts on individual lives and, due its complexity prevalence, also has major ramifications for systems economies, even threatening progress toward achieving Sustainable Development Goals. Addressing challenge requires ambitious coordinated-but so far absent-global research policy response strategy. In this interdisciplinary review, we provide synthesis state scientific evidence assess human health, systems, economy metrics, forward-looking roadmap.

Language: Английский

Distinguishing features of Long COVID identified through immune profiling DOI Open Access
Jon Klein, Jamie Wood, Jillian R. Jaycox

et al.

medRxiv (Cold Spring Harbor Laboratory), Journal Year: 2022, Volume and Issue: unknown

Published: Aug. 10, 2022

SARS-CoV-2 infection can result in the development of a constellation persistent sequelae following acute disease called post-acute COVID-19 (PASC) or Long COVID 1-3 . Individuals diagnosed with frequently report unremitting fatigue, post-exertional malaise, and variety cognitive autonomic dysfunctions ; however, basic biological mechanisms responsible for these debilitating symptoms are unclear. Here, 215 individuals were included an exploratory, cross-sectional study to perform multi-dimensional immune phenotyping conjunction machine learning methods identify key immunological features distinguishing COVID. Marked differences noted specific circulating myeloid lymphocyte populations relative matched control groups, as well evidence elevated humoral responses directed against among participants Further, unexpected increases observed antibody non-SARS-CoV-2 viral pathogens, particularly Epstein-Barr virus. Analysis mediators various hormones also revealed pronounced differences, levels cortisol being uniformly lower groups. Integration data into unbiased models identified significant critical accurate classification COVID, decreased most individual predictor. These findings will help guide additional studies pathobiology may aid future objective biomarkers

Language: Английский

Citations

198

SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery DOI Creative Commons
Justin J. Frere, Randal A. Serafini, Kerri D. Pryce

et al.

Science Translational Medicine, Journal Year: 2022, Volume and Issue: 14(664)

Published: June 7, 2022

The host response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can result in prolonged pathologies collectively referred as post-acute sequalae of COVID-19 (PASC) or long COVID. To better understand the mechanism underlying COVID biology, we compared short- and long-term systemic responses golden hamster after either SARS-CoV-2 influenza A virus (IAV) infection. Results demonstrated that exceeded IAV its capacity cause permanent injury lung kidney uniquely affected olfactory bulb (OB) epithelium (OE). Despite a lack detectable infectious virus, OB OE myeloid T cell activation, proinflammatory cytokine production, an interferon correlated with behavioral changes extending month viral clearance. These sustained transcriptional could also be corroborated from tissue isolated individuals who recovered COVID-19. data highlight molecular for persistent symptomology provide small animal model explore future therapeutics.

Language: Английский

Citations

196

Multiple sclerosis DOI
Dejan Jakimovski, Stefan Bittner, Robert Zivadinov

et al.

The Lancet, Journal Year: 2023, Volume and Issue: 403(10422), P. 183 - 202

Published: Nov. 7, 2023

Language: Английский

Citations

181

SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC) DOI Open Access
Amy D. Proal, Michael B. VanElzakker, Soo Aleman

et al.

Nature Immunology, Journal Year: 2023, Volume and Issue: 24(10), P. 1616 - 1627

Published: Sept. 4, 2023

Language: Английский

Citations

180

Human cerebral organoids — a new tool for clinical neurology research DOI Open Access
Oliver L. Eichmüller, Juergen A. Knoblich

Nature Reviews Neurology, Journal Year: 2022, Volume and Issue: 18(11), P. 661 - 680

Published: Oct. 17, 2022

Language: Английский

Citations

168

Chronic viral coinfections differentially affect the likelihood of developing long COVID DOI Creative Commons
Michael J. Peluso, Tyler‐Marie Deveau,

Sadie E. Munter

et al.

Journal of Clinical Investigation, Journal Year: 2022, Volume and Issue: 133(3)

Published: Dec. 1, 2022

BACKGROUND. The presence and reactivation of chronic viral infections, such as EBV, CMV, HIV, have been proposed potential contributors to long COVID (LC), but studies in well-characterized postacute cohorts individuals with COVID-19 over a longer time course consistent current case definitions LC are limited.

Language: Английский

Citations

150

The role of platelets in immune-mediated inflammatory diseases DOI Open Access
Marc Scherlinger, Christophe Richez, George C. Tsokos

et al.

Nature reviews. Immunology, Journal Year: 2023, Volume and Issue: 23(8), P. 495 - 510

Published: Jan. 27, 2023

Language: Английский

Citations

140

Gene–environment interactions and their impact on human health DOI Creative Commons
Samuel J. Virolainen, Andrew VonHandorf,

Kenyatta C. M. F. Viel

et al.

Genes and Immunity, Journal Year: 2022, Volume and Issue: 24(1), P. 1 - 11

Published: Dec. 30, 2022

Abstract The molecular processes underlying human health and disease are highly complex. Often, genetic environmental factors contribute to a given or phenotype in non-additive manner, yielding gene–environment (G × E) interaction. In this work, we broadly review current knowledge on the impact of interactions health. We first explain independent variation environment. next detail well-established G E that involving toxicants, pollution, viruses, sex chromosome composition. conclude with possibilities challenges for studying interactions.

Language: Английский

Citations

135

Epstein–Barr virus as a leading cause of multiple sclerosis: mechanisms and implications DOI Open Access
Kjetil Bjørnevik, Christian Münz, Jeffrey I. Cohen

et al.

Nature Reviews Neurology, Journal Year: 2023, Volume and Issue: unknown

Published: Feb. 9, 2023

Language: Английский

Citations

130

Early clues regarding the pathogenesis of long-COVID DOI Creative Commons
Michael J. Peluso, Steven G. Deeks

Trends in Immunology, Journal Year: 2022, Volume and Issue: 43(4), P. 268 - 270

Published: March 8, 2022

Language: Английский

Citations

121